• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Study: Drug-delivery micromotors treat bacterial infection in stomach

August 16, 2017 By Sarah Faulkner

Micromotors for drug deliveryResearchers at the University of California San Deigo have successfully used tiny micromotors loaded with antibiotics to treat a bacterial infection in the stomachs of mice, according to a study published today in Nature Communications.

The tiny drug-delivery vehicles are powered by gastric acid, pushing them through the stomach and releasing cargo in a specific region, based on the acid-level.

Oral drugs, including antibiotics, can be damaged by gastric acid. To effectively treat bacterial infections, healthcare workers prescribe antibiotics in combination with proton pump inhibitors to suppress the production of stomach acid.

But when proton pump inhibitors are taken for a long time or in high doses, they can bring about nasty side effects like headaches and diarrhea.

The nanoengineers at UC San Diego devised micromotors that can neutralize gastric acid and deliver antibiotics, eliminating the need for proton pump inhibitors.

“It’s a one-step treatment with these micromotors, combining acid neutralization with therapeutic action,” co-first author Berta Esteban-Fernández de Ávila said in prepared remarks.

Researchers evaluated the micromotor drug-delivery system in mice with Helicobacter pylori infections. The micromotors were given to mice once a day for five days. Then the scientists assessed the bacterial count in each mouse stomach.

They concluded that the micromotor treatment was slightly more effective than when the same dose of clarithromycin was administered with proton pump inhibitors.

The results are promising, according to researchers, but there is still work to be done. Next, the team plans to test different drug combinations with the micromotors and compare the performance of micromotors in vivo with standard therapies for stomach infections.

See the best minds in medtech live at DeviceTalks Boston on Oct. 2. 

Filed Under: Drug-Device Combinations, Featured, Nanoparticles, Pharmaceuticals, Research & Development Tagged With: University of California San Diego

IN CASE YOU MISSED IT

  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS